Visualitza VHIO - Articles científics per matèria "Recte - Càncer - Tractament"
Ara mostrant els elements 1-20 d 45
-
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
(American Association for Cancer Research, 2024-02-15) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
(Oxford University Press, 2023-03) -
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
(Frontiers Media, 2023-02-02) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
(American Association for Cancer Research, 2023-06-15) -
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
(MDPI, 2021-04-17) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
(SAGE Publications, 2021-01) -
Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer
(Elsevier, 2020-12-01) -
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
(Nature Portfolio, 2024-01) -
Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer
(SAGE Publications, 2022-07-04)